• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS WINTER & IBE GMBH OLYMPUS ESG-100, 220...240 V~,; ELECTROSURGICAL UNITS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS WINTER & IBE GMBH OLYMPUS ESG-100, 220...240 V~,; ELECTROSURGICAL UNITS Back to Search Results
Model Number WB991036
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Hepatic or Biliary Problem (4493)
Event Type  Injury  
Manufacturer Narrative
This report is being submitted report adverse events and to provide investigation results.No physical evaluation/inspection could be conducted on the suspect device as it was not returned to olympus.The device history record (dhr) for the complaint device could not be reviewed since the serial number was not provided.Olympus did a dhr review of the past 24 months and found no non-conformities related to the reported event.Olympus does not ship any device that does not meet all design and safety specifications.There was no report of olympus device malfunction and no information connecting the cause of the reported events to the device.For these reasons, the definitive cause of the reported events could not be determined.
 
Event Description
It is reported in the literature titled ¿single-duct stenting and est-additional procedures after endoscopic papillectomy: bile duct stenting and/or endoscopic sphincterotomy,¿ a patient experienced cholangitis after a procedure using olympus devices.Case with patient identifier (b)(6) will report the tjf-260v used in the procedures case with patient identifier (b)(6) will report the sd-210u-15 used in the procedures.Case with patient identifier (b)(6) will report the olympus esg-100 used in the procedures.Introduction/study aim: endoscopic papillectomy (endoscopic papillectomy: ep) is becoming a widespread resection technique for duodenal papilloma.One of the most minimally invasive but risky endoscopic procedures compared to surgical treatment, and prevention of accidental disease is important.Since ep was first reported in japan, it will be about 40 years, but the procedure has not yet been established, and the positional of endoscopic bile duct stenting (bile duct stenting) and endoscopic sphincterotomy (est) at the time of ep, which is the topic of this article, is also unclear.In this article, based on previous reports, the roles of bile duct stenting and est after ep are outlined in terms of "preventive of accidental disease (cholangitis)" and "measures to be taken in the event of accidental disease".Study method: retrospective review of previous study reports evaluating the role of bile duct stenting and est/ep in preventing accidental disease and measures taken to treat accidental disease.Results: ep was performed in 45 cases, of which 22 cases in the first term (2009-2017) were based on stenting of the bile duct and pancreatic duct, and 23 cases in the second term (2018-2021) were based on est to the bile duct orifice and pancreatic duct stenting.Acute cholangitis developed early postoperatively in 1 of 45 patients (2%).Treatment not specified.Conclusions: bile duct stenting and est after ep are outlined based on previous reports.Due to the lack of evidence, the decision to use a bile duct stent or est after ep is currently left to the judgment of each institution and surgeon, but it is important to evaluate the outflow of bile from the bile duct orifice after ep and respond appropriately.There was no report of olympus device malfunction in any procedure described in this literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OLYMPUS ESG-100, 220...240 V~,
Type of Device
ELECTROSURGICAL UNITS
Manufacturer (Section D)
OLYMPUS WINTER & IBE GMBH
kuehnstrasse 61
hamburg, hamburg 22045
GM  22045
Manufacturer Contact
daniel wladow
kuehnstrasse 61
hamburg 22045
GM   22045
4940669662
MDR Report Key13790537
MDR Text Key292500038
Report Number9610773-2022-00101
Device Sequence Number1
Product Code GEI
UDI-Device Identifier04042768910364
UDI-Public04042768910364
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K073207
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberWB991036
Device Catalogue NumberWB991036
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-